Cardiol’s focus on anti-inflammatory and anti-fib MAVERIC-2 trial will evaluate the impact of CardiolRx(TM) following cessation of interleukin-1 blocker therapy (rilonacept or anakinra ...
The Regeneron drug is competing with other IL-1 targeting drugs including Kinaret (anakinra), an IL-1 receptor antagonist approved to treat rheumatoid arthritis from Amgen of Thousand Oaks ...
At present, plenty of drugs targeting NLRP3 inflammasome have been proved to have a good effect on metabolic diseases, such as Anakinra (IL-1 receptor antagonist) and Atorvastatin (inhibits TLR4/MyD88 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback